News Quantified

PACB – pacific biosciences of california, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade) [Seeking Alpha]

Pacific Biosciences of California (NASDAQ:PACB) had its price target raised by analysts at Barclays PLC from $1.50 to $2.00. They now have an "equal weight" rating on the stock.

Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

-7.8%

BEAT

7.1%

BEAT

-7.3%

BEAT

24.2%

IN-LINE

Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC

Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30

Form 8-K PACIFIC BIOSCIENCES OF For: Nov 05

Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: ARK Investment Management LLC

Top News Gainers

3/18 Pacific Biosciences down 19% after patent ruling [Seeking Alpha] 14.8%

3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%

3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%

4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%

3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%

4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%

10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%

6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%

2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%

4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%

Top News Decliners

2/6 Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -11.6%

2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%

2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%

2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%

8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%

2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%

12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%

11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%

11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%

9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day